Company intelligence / Profile preview

Rainbow Genomics

Hong Kong, Hong Kong

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Rainbow Genomics operates commercially as a precision medicine and genetic testing company, providing clinically validated whole genome sequencing and proteomic tests for risk prediction, diagnosis, and management of more than 8,000 human disorders, rather than developing therapeutic drugs[1][4][5][8].

Therapeutic areas: NephrologyWomen's HealthOtherCardiovascularEndocrinologyNeurologyRheumatologyRare DiseasesMetabolic DisordersPsychiatryOphthalmologyOncology
Modalities: Non-pharmacological therapyDevice
Industry: Molecular Diagnostics

Partnerships

Major domestic partner in Mainland China for clinical application deployment[4]Hospital and physician partnerships in Asia Pacific for clinical genetic testing[1][4][8]

Beyond the preview

Go deeper on Rainbow Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rainbow Genomics.

Explore the full profile